Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma

被引：0
|
作者：
Yuichi Sugino
Koichiro Yamakado
Takashi Yamanaka
Masashi Fujimori
Atsuhiro Nakatsuka
Haruyuki Takaki
Yoshiyuki Takei
Hajime Sakuma
Shuji Isaji
机构：
[1] Mie University School of Medicine,Department of Radiology
[2] Hyogo College of Medicine,Department of Radiology
[3] Mie University School of Medicine,Department of Gastroenterology and Hepatology
[4] Mie University School of Medicine,Department of Hepato
来源：
Japanese Journal of Radiology | 2017年 / 35卷
关键词：
Intermediate stage; Curative treatment; Treatment allocation; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：254 / 261
页数：7
相关论文
共 50 条
  • [41] Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
    Torimura, Takuji
    Iwamoto, Hideki
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (02) : 236 - 245
  • [42] Prediction Model for Intermediate-Stage Hepatocellular Carcinoma Response to Transarterial Chemoembolization
    Jia, Fei
    Wu, Baolin
    Yan, Ruifang
    Li, Lei
    Wang, Kaiyu
    Han, Dongming
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (06) : 1657 - 1667
  • [43] Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice
    Chai, Nathan X.
    Chapiro, Julius
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2020, 37 (05) : 456 - 465
  • [44] Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy
    Hatanaka, Takeshi
    Yata, Yutaka
    Naganuma, Atsushi
    Kakizaki, Satoru
    CANCERS, 2023, 15 (06)
  • [45] Letter to Editor: 'Identification of patients with favorable prognosis after resection in intermediate-stage hepatocellular carcinoma'
    Xu, You-Jian
    Pang, Hui-Ming
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (09) : 5916 - 5917
  • [46] Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Minami, Tomohiro
    Kono, Masashi
    Chishina, Hirokazu
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    LIVER CANCER, 2015, 4 (04) : 253 - 262
  • [47] TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect health
    Peck-Radosavljevic, Markus
    LIVER INTERNATIONAL, 2010, 30 (01) : 3 - 4
  • [48] Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization
    Kim, Seong Ho
    Kim, Jin Hyoung
    Kim, Gun Ha
    Kim, Ji Hoon
    Ko, Heung-Kyu
    Chu, Hee Ho
    Shin, Ji Hoon
    Gwon, Dong Il
    Ko, Gi-Young
    Yoon, Hyun-Ki
    Aljerdah, Shakir
    Kim, Nayoung
    EUROPEAN RADIOLOGY, 2023, 33 (12) : 8736 - 8744
  • [49] Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria
    Hung, Ya-Wen
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chiu, Nai-Chi
    Hwang, Hsuen-En
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    LIVER CANCER, 2021, 10 (06) : 629 - 640
  • [50] Efficacy of local-regional treatment plus sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
    Hong, Tzu-Chun
    Tsai, Hong-Ming
    Lin, Yih-Jyh
    Chen, Chiung-Yu
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Chang, Ting-Tsung
    Han, Meng-Zhi
    Lin, Sheng-Hsiang
    Chen, Shang-Hung
    Wang, Hao-Chen
    Chen, Po-Jun
    Hsieh, Ming-Tsung
    Chiang, Hsueh-Chien
    Liu, Chieh-Yen
    Kuo, Hsin-Yu
    ADVANCES IN DIGESTIVE MEDICINE, 2023, 10 (02) : 71 - 79
12345